88
Participants
Start Date
September 14, 2023
Primary Completion Date
December 15, 2023
Study Completion Date
May 30, 2024
Influenza vaccine
Single dose of the Influenza vaccine Participants have to wait until they are invited to receive the vaccine by the general practitioner; this study does not interfere with national planning of the vaccine
Agaricus bisporus capsules
Participants have to consume 10 capsules per day containing 500 mg Agaricus bisporus powder each, corresponding to a total Agariicus bisporus powder intake of 5 g daily
Control capsules
Participants have to consume 10 capsules per day containing 500 mg maltodextrin each, corresponding to a total maltodextrin intake of 5 g daily
Maastricht University Medical Center, Maastricht
Scelta Mycofriends B.V.
UNKNOWN
CNC Grondstoffen B.V.
UNKNOWN
Maastricht University Medical Center
OTHER